Search research articles
Contact Us
Filters
Showing results (101-110 of 164) with videos related to
Page
of 17
Sort By:
European Journal of Heart Failure
|
July 21, 2021
Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitation
Klaus K Witte, David M Kaye, Janusz Lipiecki, et al.
Journal of the American Heart Association
|
June 29, 2022
Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes
Kenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
European Heart Journal
|
April 25, 2015
The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most?
Claire E Raphael, Judith A Finegold, Anthony J Barron, et al.
The American Journal of Cardiology
|
August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide
Heidi T May, Benjamin D Horne, Wayne C Levy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 30, 2016
From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure
Omar F AbouEzzeddine, Benjamin French, Sultan A Mirzoyev, et al.
The American Journal of Cardiology
|
June 14, 2005
Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure
Kier V Huehnergarth, Dariush Mozaffarian, Mark D Sullivan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 19, 2010
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement
Eric S Ketchum, Alec J Moorman, Daniel P Fishbein, et al.
JAMA
|
June 5, 2008
Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure
Larry A Allen, Jonathan E Yager, Michele Jonsson Funk, et al.
JACC. Heart Failure
|
March 16, 2015
Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials
S M Afzal Sohaib, Judith A Finegold, Sukhjinder S Nijjer, et al.
ESC Heart Failure
|
July 29, 2021
Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels
Ryoma Fukuoka, Shun Kohsaka, Yasuyuki Shiraishi, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 164) with videos related to
Sort By:
Page
of 17
European Journal of Heart Failure
|
July 21, 2021
Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitation
Klaus K Witte, David M Kaye, Janusz Lipiecki, et al.
Journal of the American Heart Association
|
June 29, 2022
Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes
Kenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
European Heart Journal
|
April 25, 2015
The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most?
Claire E Raphael, Judith A Finegold, Anthony J Barron, et al.
The American Journal of Cardiology
|
August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide
Heidi T May, Benjamin D Horne, Wayne C Levy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 30, 2016
From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure
Omar F AbouEzzeddine, Benjamin French, Sultan A Mirzoyev, et al.
The American Journal of Cardiology
|
June 14, 2005
Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure
Kier V Huehnergarth, Dariush Mozaffarian, Mark D Sullivan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 19, 2010
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement
Eric S Ketchum, Alec J Moorman, Daniel P Fishbein, et al.
JAMA
|
June 5, 2008
Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure
Larry A Allen, Jonathan E Yager, Michele Jonsson Funk, et al.
JACC. Heart Failure
|
March 16, 2015
Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials
S M Afzal Sohaib, Judith A Finegold, Sukhjinder S Nijjer, et al.
ESC Heart Failure
|
July 29, 2021
Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels
Ryoma Fukuoka, Shun Kohsaka, Yasuyuki Shiraishi, et al.
Page
of 17